Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan T Connell

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Blood|February 27, 2019
Fostamatinib for the treatment of chronic immune thrombocytopeniaNathan T Connell, Nancy Berliner
Hematology/Oncology Clinics of North America|April 3, 2012
Does my patient have a life- or limb-threatening thrombocytopenia?Nathan T Connell, Joseph D Sweeney
Journal of Thrombosis and Thrombolysis|June 23, 2019
Cost-effectiveness of edoxaban versus dalteparin for the treatment of cancer-associated thrombosisNathan T Connell, Jean M Connors
Rhode Island Medical Journal (2013)|July 1, 2015
Attending Physician Attitudes Toward Choice of Oral Anticoagulant for the Treatment of Venous ThromboembolismNathan T Connell, James N Butera
Hematology/Oncology Clinics of North America|August 15, 2021
Acquired von Willebrand SyndromeArielle L Langer, Nathan T Connell
Thrombosis Research|November 27, 2021
To aPTT or not to aPTT: Evaluating the optimal monitoring strategy for unfractionated heparinNathan T Connell, Katelyn W Sylvester
Medicine and Health, Rhode Island|September 8, 2011
Splenic cyst manifesting as gastric outlet obstructionNathan T Connell, Bethany J Gentilesco
Therapeutic Advances in Hematology|September 20, 2019
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuriaRobert M Stern, Nathan T Connell
Current Opinion in Hematology|August 3, 2020
Venous thromboembolism in the hormonal milieuNathan T Connell, Jean M Connors
The American Journal of Medicine|February 16, 2023
The ReplyEbrahim Barkoudah, Carson Moss, Nathan T Connell
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Blood|February 27, 2019
Fostamatinib for the treatment of chronic immune thrombocytopeniaNathan T Connell, Nancy Berliner
Hematology/Oncology Clinics of North America|April 3, 2012
Does my patient have a life- or limb-threatening thrombocytopenia?Nathan T Connell, Joseph D Sweeney
Journal of Thrombosis and Thrombolysis|June 23, 2019
Cost-effectiveness of edoxaban versus dalteparin for the treatment of cancer-associated thrombosisNathan T Connell, Jean M Connors
Rhode Island Medical Journal (2013)|July 1, 2015
Attending Physician Attitudes Toward Choice of Oral Anticoagulant for the Treatment of Venous ThromboembolismNathan T Connell, James N Butera
Hematology/Oncology Clinics of North America|August 15, 2021
Acquired von Willebrand SyndromeArielle L Langer, Nathan T Connell
Thrombosis Research|November 27, 2021
To aPTT or not to aPTT: Evaluating the optimal monitoring strategy for unfractionated heparinNathan T Connell, Katelyn W Sylvester
Medicine and Health, Rhode Island|September 8, 2011
Splenic cyst manifesting as gastric outlet obstructionNathan T Connell, Bethany J Gentilesco
Therapeutic Advances in Hematology|September 20, 2019
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuriaRobert M Stern, Nathan T Connell
Current Opinion in Hematology|August 3, 2020
Venous thromboembolism in the hormonal milieuNathan T Connell, Jean M Connors
The American Journal of Medicine|February 16, 2023
The ReplyEbrahim Barkoudah, Carson Moss, Nathan T Connell
Pageof 9